| Literature DB >> 31392820 |
Mahdi Moradpour1, Siti Nor Akmar Abdulah1,2.
Abstract
Clustered regularly interspaced short palindromic repeat (CRISPR) and Cas9-associated protein systems provide a powerful genetic manipulation tool that can drive plant research forward. Nuclease-dead Cas9 (dCas9) is an enzymatically inactive mutant of Cas9 in which its endonuclease activity is non-functional. The applications of CRISPR/dCas9 have expanded and diversified in recent years. Originally, dCas9 was used as a CRISPR/Cas9 re-engineering tool that enables targeted expression of any gene or multiple genes through recruitment of transcriptional effector domains without introducing irreversible DNA-damaging mutations. Subsequent applications have made use of its ability to recruit modifying enzymes and reporter proteins to DNA target sites. In this paper, the most recent progress in the applications of CRISPR/dCas9 in plants, which include gene activation and repression, epigenome editing, modulation of chromatin topology, live-cell chromatin imaging and DNA-free genetic modification, will be reviewed. The associated strategies for exploiting the CRISPR/dCas9 system for crop improvement with a dimer of the future of the CRISPR/dCas9 system in the functional genomics of crops and the development of traits will be briefly discussed.Entities:
Keywords: CRISPR/dCas9; CRISPR/dCas9 ribonucleoproteins; chromatin imaging; chromatin topology; epigenome editing; sgRNAs; transcriptional activation; transcriptional regulation
Mesh:
Substances:
Year: 2019 PMID: 31392820 PMCID: PMC6920162 DOI: 10.1111/pbi.13232
Source DB: PubMed Journal: Plant Biotechnol J ISSN: 1467-7644 Impact factor: 9.803
Figure 1Major applications of the CRISPR/dCas9 system in plant genomics research.
Figure 3Modified strategy for CRISPR/dCas9‐mediated gene activation in plants. The modified dCas9 system consists of a dCas9 that can be easily fused to transcriptional activators such as VP64, EDLL, TAL and other TADs. The accompanying sgRNA can also be modified to include two RNA aptamers for binding with MS2 coat proteins that are also fused to transcriptional activators.
Figure 2Schematic illustration of the use of dCas9 as a modular system for transcriptional regulator attachment. dCas9 is fused to effectors, transcription activators or repressors, for targeted gene regulation.
Summary of reports using the first strategy: fusion of various activators in tandem with dCas9 for regulating gene expression in plants
| Plant species | Design | Delivery | Detection | References | ||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Gene | dCas9 expression cassette | sgRNA expression cassette | Method | Type of regulation | Relative gene expression (fold) | Assay | ||||
| Plasmid | Promoter of dcas9 | Plasmid | Promoter of sgRNA | |||||||
|
| LexA | dCas9‐VP64 | 35S | sgRNA‐LexA‐5′G |
| PEG‐mediated protoplast transfection | Activation | 2.4 | RT‐qPCR | Li |
|
| dCas9‐TV | sgRNA‐WRKY30 | 138.8 | |||||||
|
| sgRNA‐ RLP23 |
| 44.2 | |||||||
| pFGC‐dCas9‐VP64 | sgRNA‐RLP23‐4 |
| Flora dip | 0.5 | ||||||
| pFGC‐dCas9‐TV | sgRNA‐RLP23‐4 | 32.3 | ||||||||
|
|
| LUC/dCas9‐TV | sgRNA‐OsGW7‐2 |
| PEG‐mediated protoplast transfection | 79 | ||||
|
| sgRNA‐OsER1‐2 | 62 | ||||||||
| dCas9‐TV‐6 × His |
| sgRNA‐OsER1‐2 | ‐ | RNP‐mediated | 13 | |||||
|
|
| dCas9‐TV‐6 × His | sgRNA‐CDG1 | 191.7 | ||||||
|
| sgRNA‐WRKY30 | 80.3 | ||||||||
|
| sgRNA‐RLP23‐4 | 37.3 | ||||||||
|
|
| dCas9‐TV | 35S | sgRNA‐HsASCL1 |
| Co‐transfection with Lipofectamine LTX with PLUS | 46 | |||
|
| sgRNA‐HsOCT4 | 14.6 | ||||||||
Summary of reports using the second strategy: recruitment of transcriptional activators via modified gRNA scaffolds for regulating gene expression in plants
| Plant species | Design | Delivery | Detection | References | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene | dCas9 expression cassette | sgRNA expression cassette | Multiplex strategy | Method | Type of regulation | Relative gene expression (fold) | Assay | ||||
| Plasmid | Promoter of dcas9 | Plasmid | Promoter of sgRNA | ||||||||
|
|
| dCas9‐TV | 35S | Normal sgRNA‐ |
| Yes, co‐expressing dCas9–TV with three sgRNAs | PEG‐mediated transfection | Activation | 369.3 | RT‐qPCR | Li |
| dCas9‐TV MCP‐4EE‐VP128 | SAM sgRNA‐ | 359.1 | |||||||||
| dCas9‐MCP‐TV | SAM sgRNA‐ | 359.1 | |||||||||
|
| pco‐dCas9‐VP64 |
|
|
| Multiplex gRNAs by Golden Gate Assembly & MultiSite Gateway | Flora dip | 2–7 | RT‐qPCR | Lowder | ||
|
| pco‐dCas9‐VP64 |
| 3–7.5 | ||||||||
|
| pco‐dCas9‐VP64 |
| Activation by RNA‐guided targeting of promoter methylation sites. | 400 | |||||||
|
| pco‐dCas9‐3X(SRDX) |
| Repression | −0.6 | |||||||
|
| dCas9‐VP64‐ EDLL |
| Activation | 200 | Kaufmann and Walker ( | ||||||
|
| dCas9‐VP64‐EDLL |
| 2–3 | ||||||||
|
| dCas9‐VP64‐T2A‐MS2‐EDLL |
| 30 | ||||||||
|
| dCas9‐VP64‐T2A‐MS2‐EDLL |
| 35 | ||||||||
|
| dCas9‐VP64‐T2A‐MS2‐VP64 |
| 50 | ||||||||
|
| dCas9‐VP64‐T2A‐MS2‐VP64 |
| 1500 | ||||||||
|
| Os03g01240, Os04g39780 & Os11g35410 | dCas9‐VP64 | Maize Ubi1 | Os03g01240‐gR1 (N21), Os04g39780‐gR1 (N23) & Os11g35410‐gR1 (N25) |
| Golden Gate Assembly & MultiSite Gateway | PEG‐mediated transfection | Activation. | 1–2.5 | RT‐qPCR | Lowder |
| Os03g01240, Os04g39780 and Os11g3541 | dCas9‐VP64‐T2A‐MS2‐VP64‐N21‐23‐25 | Os03g01240‐gR1 (N21), Os04g39780‐gR1 (N23) & Os11g35410‐gR1 (N25) | 2.5–7 | ||||||||
|
| Target telomere DNA sequence | sp/sa‐dCas9 | Ubi4 | sgRNA‐telomere |
| Gibson Assembly cloning | Agroinfiltration | Visualization of tandem repeats in live plant cells | 21–42 | Immunofluorescence analysis and fluorescence | Dreissig |
Summary of reports using the third strategy: multiplex transcription activator system for synchronized activation of multiple genes for regulating gene expression in plants
| Plant species | Design | Delivery | Detection | References | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gene | dCas9 expression cassette | sgRNA expression cassette | Multiplex strategy | Method | Type of regulation | Relative gene expression (fold) | Assay | ||||
| Plasmid | Promoter of dcas9 | Plasmid | Promoter of sgRNA | ||||||||
|
|
| dCas9‐TV | 35S | sgRNA‐WRKY30sgRNA‐RLP23 sgRNA‐CDG1‐4 |
| Yes, co‐expressing dCas9–TV with three sgRNAs | PEG‐mediated transfection |
Simultaneous Activation | 9–13 | RT‐qPCR | Li |
|
| mTALE‐ | 2 × 35S |
|
| Flora dip |
| Lowder | ||||
|
| Act |
| |||||||||
|
|
| ||||||||||
|
| Os03g01240, Os04g39780 & Os11g35410 | dCas9‐VP64 | Maize Ubi1 | Os03g01240‐gR1 (N21), Os04g39780‐gR1 (N23) & Os11g35410‐gR1 (N25) |
| Multiplex gRNAs by Golden Gate Assembly & MultiSite Gateway | PEG‐mediated transfection | Activation | 2–2.5 | ||
| Os03g01240, Os04g39780 and Os11g3541 | dCas9‐VP64‐T2A‐MS2‐VP64‐N21‐23‐25 | Os03g01240‐gR1 (N21), Os04g39780‐gR1 (N23) & Os11g35410‐gR1 (N25) | 3–7 | ||||||||